Decline in breast cancer cases likely linked to reduced Use of hormone replacement.

The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug.

FDA has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic breast cancer.

A new gamma camera technique for the detection of small breast tumors.

Postmenopausal women with early stage, hormone sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs.

The experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer.

Addition of Fuji CR Mammography Technology to Siemens' portfolio provides facilities with options for breast cancer screening.

Introducing a more potent form of a family of drugs called bisphosphonates to breast cancer patients with bone disease progression improves their quality of life.

FDA expands the use of Herceptin, a Genentech breast cancer drug, for early stage breast cancer treatment after primary therapy.

Many newly diagnosed breast cancer patients have unrecognized and undertreated psychological needs.

For women who have had surgery for early breast cancer, it may not matter whether they receive follow up chemotherapy before, after or during radiation therapy.

Black women with breast cancer were more likely to have larger, later stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment.

Vitamin D may help curb breast cancer progression, according to a study published today in the Journal of Clinical Pathology.

Findings may lead to new ways to detect and destroy cells before they become cancerous.

Women undergoing radiation treatment for breast cancer benefit from moderate intensity, regular aerobic activity.